Skip to main content
. 2021 Sep 2;2(6):zqab045. doi: 10.1093/function/zqab045

Table 1.

Participant Characteristics

Outcome CH (n = 24) MCI (n = 11) MCI + Med (n = 15) P-value
Age (y) 72.5 [8.5] 69.6 [7.4] 74.9 [7.3] 0.253
Sex (#, % female) 12 [48%] 9 [82%] 7 (47%] 0.128
APOE4 (#, % carrier) 9 [36%] 8 [73%] 7 [47%] 0.126
Education (y) 16.9 [1.7] 16.9 [2.3] 15.8 [2.3] 0.250
Overweight/Obesity (#,%) 15 [62%] 3 [27%] 9 [60%] 0.130
Activity per day (counts) 12 689.8 [3470] 14 936 [3242] 10 121.0 [3014] 0.010*,+
VO2 peak (mL/kg/min) 26.5 [6.9] 25.8 [4.2] 22.8 [6.7] 0.155
GXT duration (min) 13.1 [2.6] 12.4 [2.5] 9.51 [3.3] <0.001*,+
Resting RER 0.831 [0.08] 0.773 [0.04] 0.780 [0.08] 0.031#,+
Peak HR 159.8 [20.1] 154.9 [15.0] 148.7 [27.4] 0.437
BMD 1.25 [0.19] 1.11 [0.16] 1.20 [0.13] 0.228
Waist Hip Ratio 0.883 [0.12] 0.814 [0.08] 0.917 [0.11] 0.276
Lean mass (kg) 47.5 [10.7] 37.9 [10.6] 48.3 [10.4] 0.100
Fat mass (kg) 27.0 [9.3] 19.5 [5.1] 29.9 [11.2] 0.027 +

APOE; Apolipoprotein E, BMI; body mass index, GXT; graded exercise test, RER; respiratory exchange ratio, and HR; heart rate. Mean values are given as means [SD] and were assessed using ANCOVA. P < .05 #CH vs MCI, +CH vs MCI + med, and *MCI vs MCI + med.